Siren Biotechnology, a trailblazer in the fight against cancer, is excited to announce that it has successfully raised $28,000,000 in its latest funding round. This significant investment underscores the confidence of investors in Siren鈥檚 groundbreaking approach and the potential of its Universal AAV Immuno-Gene Therapy. At Siren, the belief is clear: the fight against cancer needs new, big, bold ideas, and the company is fully committed to delivering on that promise by combining two transformative therapeutic technologies鈥擜AV gene therapy and cytokine immunotherapy鈥攊nto one powerful, reimagined modality. This funding will be strategically deployed to accelerate preclinical and clinical research, optimize delivery systems, and expand manufacturing capabilities to meet future demand. Furthermore, the new capital is set to bolster collaborations with leading research institutions and accelerate the development of advanced protocols that not only target tumor cells directly but also stimulate robust anti-tumor immunity. By integrating these two cutting-edge technologies, Siren is poised to overcome the critical challenges that have traditionally hindered progress in cancer treatment. The infusion of funds marks a pivotal milestone in the company鈥檚 ongoing mission to redefine cancer care and provide hope to patients who desperately need innovative therapeutic options. As the company moves forward, Siren Biotechnology remains steadfast in its commitment to innovation, excellence, and the relentless pursuit of solutions that have the potential to transform the landscape of cancer treatment, ultimately improving outcomes and saving lives.
Breaking Boundaries in Cancer Treatment: Siren Biotechnology Secures $28M to Launch Universal AAV Immuno-Gene Therapy
Recently funded 路 $28.0MBiotechnology
Get the full Siren Biotechnology company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
